Location:
Barcelona
- Spain (3 days working from the office and 2 days working from home) AtAlexion, AstraZeneca Rare Disease, this role offers the opportunity to shape access for transformative medicines in areas of high unmet need and make a meaningful impact for patients living withrare neurological diseases. You will operate in a highly visible, strategic position with broad cross-functional exposure, leading portfolio-level market access, pricing, and reimbursement strategy across key markets, with a particular focus on theNMOSDindication. This is an opportunity for an experienced market access leader to influence critical launch and lifecycle decisions, navigate complex payer environments, and play a central role in advancing our ambition withinNeurology. Whatyou’llwilldo: Join a highly valued, strategic team that is fundamental to realizing the potential of our life-changing medicines. Through our work, AstraZenecais able toensure that appropriate access is provided to our transformative therapies. Alexion, AstraZeneca Rare Disease’sGlobal Value Access and Pricing (GVAP) team is seeking a qualifiedDirectorto join a dynamic and growing team, with responsibility forNeurologyindications, including near-term new product launches and label expansions. As a key member of theGVAPteam, you will help shape and execute global value, access, and pricing strategies across theNeurology portfolioin selected key EU markets, withparticular strategicfocus on theNMOSD indicationand its lifecycle management This is a strategic role that leverages your understanding and application of global healthcare and health technology assessment (HTA) systems, competitive insights, and clinical knowledge to shape market access, pricing, and reimbursement success for critical product launches and indications.



The idóneo candidate for this role will have deep expertise in global payer, HTA, and reimbursement ecosystems, with a strong track record of driving market access, pricing, and reimbursement success withinrare diseases and Neurology. You will be responsible for: Value
* Lead and drive cross-functional development of a clear, differentiated value proposition forNMOSD, while influencing without authority and navigating complex organizational systems.
* Collaborate with cross-functional teams to ensure that evidence generation plans and real-world evidence (RWE) are incorporated effectively to deliver a comprehensive value proposition, reduce uncertainty for payers, and optimize patient access. This includes securing timely country input on endpoints and evidence generation plans in priority target countries.
* Provide support to theGMMA Commercialteam to advanceNMOSD lifecycle management (LCM)through governance milestones focused on market access potential, evidence, andtarget product profile (TPP) requirements. Access
* Leaddevelopmentofglobal market access and pricing strategies-activitiesandsupport implementationin close partnership with country access representativesofassigned countries
* Lead the assessment of pricing and reimbursement (P&R;) risks and opportunities, and the implementation of corresponding mitigation actions specific toNeurology.
* Create and roll out strategic value, access,



and pricing communication tools and materials forNMOSDto support localP&R; submissions and negotiations, such as pricing frameworks, negotiation strategies, and toolkits, in alignment with the enterprise-wide launch framework.
* Lead the update of the global reimbursement dossier forNMOSDand the overall cross-functional market access readiness plans forNeurology, in close collaboration with key countries and support functions ( HEOR, Medical, and Commercial).
* Represent theGVAPperspective and strategy across various cross-functional teams, including theGlobal Value Sub-TeamandGlobal Launch Team, and provide updates and guidance to local teams as needed.
* Own the monthlyNeurologypayer working group to share the latest evidence and drive best practice sharing across countries.
* Understand and incorporate thepatientperspective on thedisease, andrecommend strategies that support thepatientvoice in key payer negotiations. Pricing
* Support the development oftheNeurologypricing strategy.
* Conduct payer and value assessments to identify key market-specific P&R; drivers and barriers, develop differentiated value propositions, and inform evidence generation plans, regulatory strategy, and development decisions.
* For the top EU Neurology markets, lead and co-create market-level P&R; strategies and support P&R; submissions and negotiations to drive positive outcomes.
* Review P&R; cases submitted bymarkets, andsupport markets in maintaining value while unlocking local accessworking in close partnership with country access representatives and /or access International shared marketsGVAPteam for relevant countries.
* Offer critical strategic input to inform access and pricing assumptions, enabling accurate, market-driven LTP assumptions.
* Communicat

📌 Global Pricing (Cataluña)
🏢 Alexion
📍 Cataluña